165 related articles for article (PubMed ID: 28325367)
1. Contribution of MAML1 in esophageal squamous cell carcinoma tumorigenesis.
Hashemi Bidokhti M; Abbaszadegan MR; Sharifi N; Abbasi Sani S; Forghanifard MM
Ann Diagn Pathol; 2017 Apr; 27():79-82. PubMed ID: 28325367
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis elucidates the roles of MAML1 and Twist1 in esophageal squamous cell carcinoma aggressiveness and metastasis.
Forghanifard MM; Moaven O; Farshchian M; Montazer M; Raeisossadati R; Abdollahi A; Moghbeli M; Nejadsattari T; Parivar K; Abbaszadegan MR
Ann Surg Oncol; 2012 Mar; 19(3):743-9. PubMed ID: 22006371
[TBL] [Abstract][Full Text] [Related]
3. Role of Msi1 and MAML1 in Regulation of Notch Signaling Pathway in Patients with Esophageal Squamous Cell Carcinoma.
Moghbeli M; Forghanifard MM; Sadrizadeh A; Mozaffari HM; Golmakani E; Abbaszadegan MR
J Gastrointest Cancer; 2015 Dec; 46(4):365-9. PubMed ID: 26294058
[TBL] [Abstract][Full Text] [Related]
4. Role of MAML1 and MEIS1 in Esophageal Squamous Cell Carcinoma Depth of Invasion.
Abbaszadegan MR; Moghbeli M
Pathol Oncol Res; 2018 Apr; 24(2):245-250. PubMed ID: 28462489
[TBL] [Abstract][Full Text] [Related]
5. MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1.
Forghanifard MM; Azaraz S; Ardalan Khales S; Morshedi Rad D; Abbaszadegan MR
Mol Biol Rep; 2020 Apr; 47(4):2659-2668. PubMed ID: 32180088
[TBL] [Abstract][Full Text] [Related]
6. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
7. Notch Signaling Target Genes are Directly Correlated to Esophageal Squamous Cell Carcinoma Tumorigenesis.
Forghanifard MM; Taleb S; Abbaszadegan MR
Pathol Oncol Res; 2015 Apr; 21(2):463-7. PubMed ID: 25361534
[TBL] [Abstract][Full Text] [Related]
8. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
Shan B; Man H; Liu J; Wang L; Zhu T; Ma M; Xv Z; Chen X; Yang X; Li P
Oncol Rep; 2016 Sep; 36(3):1551-61. PubMed ID: 27430162
[TBL] [Abstract][Full Text] [Related]
9. Sam68 promotes cellular proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
Wang Y; Liang L; Zhang J; Li M; Zhu J; Gong C; Yang L; Zhu J; Chen L; Ni R
Tumour Biol; 2015 Nov; 36(11):8735-45. PubMed ID: 26050229
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of BRUCE protein in esophageal squamous cell carcinoma.
Salehi S; Jafarian AH; Forghanifard MM
Ann Diagn Pathol; 2016 Oct; 24():47-51. PubMed ID: 27649954
[TBL] [Abstract][Full Text] [Related]
11. Role of MAML1 in targeted therapy against the esophageal cancer stem cells.
Moghbeli M; Mosannen Mozaffari H; Memar B; Forghanifard MM; Gholamin M; Abbaszadegan MR
J Transl Med; 2019 Apr; 17(1):126. PubMed ID: 30992079
[TBL] [Abstract][Full Text] [Related]
12. Na+/H+ exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma.
Ariyoshi Y; Shiozaki A; Ichikawa D; Shimizu H; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Marunaka Y; Otsuji E
Oncotarget; 2017 Jan; 8(2):2209-2223. PubMed ID: 27902974
[TBL] [Abstract][Full Text] [Related]
13. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
[TBL] [Abstract][Full Text] [Related]
14. HES1 as an independent prognostic marker in esophageal squamous cell carcinoma.
Taleb S; Abbaszadegan MR; Moghbeli M; Roudbari NH; Forghanifard MM
J Gastrointest Cancer; 2014 Dec; 45(4):466-71. PubMed ID: 25139105
[TBL] [Abstract][Full Text] [Related]
15. TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma.
Fahim Y; Yousefi M; Izadpanah MH; Forghanifard MM
Mol Cell Biochem; 2020 Nov; 474(1-2):181-188. PubMed ID: 32712748
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of activator of G-protein signaling 3 decreases the proliferation of esophageal squamous cell carcinoma.
Shi H; Ren H; Yang X; Zhu H; Yao L; Hang Q; Mao H; Huang Y; Zhang J; Wang Y
Pathol Res Pract; 2015 Jun; 211(6):449-55. PubMed ID: 25812748
[TBL] [Abstract][Full Text] [Related]
17. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
[TBL] [Abstract][Full Text] [Related]
18. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
19. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
20. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
